ReviewFrontiers in immunology2023

Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.

James D Chalmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.